April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
On Hyperspectral Signatures of Drusen
Author Affiliations & Notes
  • N. lee
    Biomedical Engineering, Ophthalmology,
    Columbia University, New York, New York
  • A. A. Fawzi
    Biomedical Engineering, Ophthalmology,
    Doheny Eye Institute, University of Southern California, Los Angeles, California
  • P. Sajda
    Biomedical Engineering, Ophthalmology,
    Columbia University, New York, New York
  • A. F. Laine
    Biomedical Engineering, Ophthalmology,
    Columbia University, New York, New York
  • G. Martin
    Reichert Ophthalmic Instruments Inc., Depew, New York
  • M. S. Humayun
    Ophthalmology, Biomedical Engineering and Cell and Neurobiology,
    Doheny Eye Institute, University of Southern California, Los Angeles, California
  • R. T. Smith
    Ophthalmology, Biomedical Engineering and Cell and Neurobiology,
    Columbia University, New York, New York
  • Footnotes
    Commercial Relationships  N. lee, None; A.A. Fawzi, Reichert, Inc. (Grant Support), F; P. Sajda, None; A.F. Laine, None; G. Martin, Reichert, Inc. (Employee), E; M.S. Humayun, Reichert, Inc. (Grant Support), F; R.T. Smith, None.
  • Footnotes
    Support  1 R01 EY015520-01A1,New York Community Trust (RTS) ,Research To Prevent Blindness
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 4934. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      N. lee, A. A. Fawzi, P. Sajda, A. F. Laine, G. Martin, M. S. Humayun, R. T. Smith; On Hyperspectral Signatures of Drusen. Invest. Ophthalmol. Vis. Sci. 2010;51(13):4934.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose:
 

Drusen, the hallmark lesions of age related macular degeneration (AMD), are biochemically heterogeneous and the identification of their biochemical distribution is key to understanding AMD. Yet the challenges are to develop imaging technology and analysis tools which respect the physical generation of the hyperspectral signal in the presence of noise and multiple mixed sources while maximally exploiting the full data dimensionality to uncover clinically relevant spectral signatures.

 
Methods:
 

7 patient eyes with drusen were imaged with the snapshot hyperspectral camera previously described (doi:10.1117/1.2434950). Regions of interest (ROI’s) of drusen were identified in each image. Multiple images were acquired of one eye. We performed statistical intra-subject analysis to investigate the reproducibility of non-negative matrix factorization (NMF) in AMD patients with different types of drusen. Given a data matrix D and a positive integer r the NMF problem is to compute a decomposition with r being the low-rank factor, W the basis vectors, and H the linear encoding representing the mixing coefficients.

 
Results:
 

Figure 1 shows central slices of 5 different ROIs for patient P=c. In each ROI a drusen sensitivity spectrum was recovered with a response peak between 550 and 600nm. This spectrum had low variability across different ROIs within a patient (mean-standard error (σ) = 0.01) and between patients (σ=0.041).  

 
Conclusions:
 

Snapshot hyperspectral images analyzed with NMF, which imposes physically realistic positivity constraints on the mixing process, recovered spectral profiles that reliably identified drusen. The recovered spectra were consistently similar for drusen in different areas of the macula from the same eye and also in different eyes. Our results suggest that hyperspectral imaging can detect biochemically meaningful components of drusen.

 
Keywords: age-related macular degeneration • computational modeling • image processing 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×